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teracts with the other cytokines that
modify the action of G-CSF. Our data
may help explain the complicated cyto-
kines network (including the association
between calcium and G-CSF) in tumors
that simultaneously produce PTHrP and
G-CSF.
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Re: Risk of Urinary Tract
Cancers Following Kidney or
Ureter Stones
A Swedish record-linkage study (1),
based on a cohort of 61 114 patients hos-
pitalized for kidney or ureter stones fol-
lowed for up to 18 years, found a stan-
dardized incidence ratio of bladder
cancer of 1.4 based on 319 cases. The
association was stronger in women, but
information was not available to allow
for possible confounding factors. Evi-
dence from case–control studies is still
open to discussion. The odds ratios
(ORs) were 2.2 in males in an earlier
U.S. study (2), around 1.5 in a large
multicentric U.S. study (3), and 1.0 in a
Danish study (4). Three additional case–
control studies (5–7) found ORs be-
tween 1.2 and 1.4.
Urinary tract stones might induce
chronic irritation that may lead to pro-
liferative urothelial changes, or me-
chanical effect of stones on the epithe-
lium might increase absorption and/or
exposure to carcinogens in the urine, or
they may be markers of chronic infec-
tions or conditions, which may, in turn,
enhance bladder cancer risk. However,
it remains open to discussion whether
the moderate relationship observed in
case–control studies reflects a causal as-
sociation rather than a more accurate re-
call of urinary symptoms by bladder
cancer cases than controls.
Therefore, we updated our analysis
on the relationship between urinary tract
stones and risk of bladder cancer in a
case–control study carried out in North-
ern Italy between 1985 and 1992 (6).
Cases were 431 subjects (361 men and
70 women; median age, 63 years [range,
27–79 years]) with incident histo-
logically confirmed bladder cancer.
Controls were 813 subjects (638 men
and 175 women; median age, 61 years
[range, 23–79 years]) admitted to the
same hospital for various acute con-
ditions not related to smoking or other
known or likely risk factors for blad-
der cancer. A total of 21 (5%) case
patients and 40 (5%) of control sub-
jects reported a history of urinary tract
stones (Table 1). The multivariate OR of
bladder cancer was 1.0. Separate analy-
sis in women found a nonsignificant OR
of 2.2.
Thus, this study confirms that no ma-
jor association emerged between urinary
tract stones and bladder cancer. If any
association exists, this may be stronger
in women.
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Table 1. Distribution of 431 cases of bladder cancer and 813 controls and corresponding odds ratios
with 95% confidence intervals, according to history of urinary tract stones (Milan, 1985–1992)
History
of stones
Bladder cancer Control subjects Odds ratios (95% confidence intervals)*
Men Women Men Women Men Women All
No 343 67 602 171 1† 1† 1†
Yes 18 3 36 4 1.0 (0.5–1.8) 2.2 (0.4–10.8) 1.0 (0.6–1.8)
*Estimates from multiple logistic regression equations, including terms for age, education, and smoking
habit.
†Reference category.
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